Real-world use of biomarkers for Parkinsonism: Should I do this (pSyn) or DaT?
Objective: To examine the utility of commercially available skin phosphorylated alpha-synuclein deposition test (pSyn) in patients with clinically ambiguous parkinsonism and its concordance with dopamine…Comparison of Composite Method Calculations for Monitoring Disease Progression in Early Parkinson’s Disease
Objective: Objective: To evaluate the influence of composite scoring methodologies using digital measures of gait, tremor, and bradykinesia to monitor disease progression over one year…Subthalamic Nucleus Stimulation Modulates Cognitive Theory of Mind in Parkinson’s Disease
Objective: This study aims to investigate the effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on ToM using the Parkinson’s disease (PD) model. Background:…Misdiagnosis of Cognitive Impairment in Parkinson’s disease
Objective: We explored potential bias to diagnose cognitive impairment in People with Parkinson’s (PwP) followed in the Parkinson’s Progressive Markers Initiative (PPMI). Background: In primary…Investigating an Emerging Anxiety-like Phenotype in a Novel Bilateral Rodent Model of Parkinsonian Alpha-Synuclein Pathology
Objective: Investigate an emerging anxiety-like phenotype at various timepoints in a novel bilateral rodent model of parkinsonian alpha-synuclein pathology. Background: Parkinson’s Disease (PD) anxiety poses…A Network Analysis shows How Impulsive-Compulsive Behaviors correlates with Levodopa-Induced Dyskinesia
Objective: To study Impulsive Compulsive Behaviors (ICBs) and Levodopa-Induced Dyskinesias (LIDs) in Young Onset Parkinson's disease (YOPD) patients. Background: Parkinson's disease (PD) is a neurodegenerative…Fatigue in Parkinson’s Disease: Prevalence and Risk Factors
Objective: To determine the prevalence of fatigue among people with PD (PwP) in comparison to the general population and to identify fatigue associated factors. Background:…Exploring Supervised and Real-World Mobility in People with Parkinson’s Disease with and without Nocturnal Hypokinesia
Objective: To evaluate supervised and real-world mobility in people with Parkinson’s disease (PwPD) with and without nocturnal hypokinesia (NH). Background: Mobility impairment and NH are…The effect of Diabetes Mellitus and Cardiovascular disease on Parkinson’s disease
Objective: To understand the impact of the comorbidities; namely Type 2 Diabetes Mellitus (DM) and/or cardiovascular disease (CVD) on the clinical features of Parkinson’s disease…Subjective Sleep Quality and Pathological Sleepiness in Veterans with Parkinson’s Disease
Objective: To determine the subjective sleep quality and its association with pathological sleepiness in Veterans with Parkinson's disease (PD). Background: Sleep quality issues and pathological…
- « Previous Page
- 1
- …
- 137
- 138
- 139
- 140
- 141
- …
- 436
- Next Page »